As caregivers, we are all aware that residents with a diagnosis of Alzheimer’s disease are at higher risk for falls and head injuries. What we didn’t know until recently is that current trends in treating the symptoms of Alzheimer’s disease with antipsychotic medications may actually be increasing these risks.

The results of a recent study published in the Journal of the American Geriatrics Society recommends that the use of these medications be restricted to treat only the most severe neuropsychiatric symptoms based on the AGS BEERS Criteria. Considering we recently discussed negative outcomes related to antipsychotic use in residents with delirium, maybe it is really time to take a deeper dive into how and why we are using antipsychotic medications to treat our residents.

Share this information with your prescribing physicians, educate your team on these findings and remember it is our responsibility to provide appropriate care that meets current standards.